AQR Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,113
Closed -$238K 2390
2022
Q2
$238K Sell
15,113
-5,031
-25% -$76.8K ﹤0.01% 1938
2022
Q1
$306K Sell
20,144
-7,727
-28% -$118K ﹤0.01% 1961
2021
Q4
$428K Sell
27,871
-143,571
-84% -$1.89M ﹤0.01% 1871
2021
Q3
$1.49M Buy
171,442
+74,225
+76% +$677K ﹤0.01% 1336
2021
Q2
$993K Sell
97,217
-112,918
-54% -$1.19M ﹤0.01% 1593
2021
Q1
$2.51M Sell
210,135
-184,195
-47% -$2.09M ﹤0.01% 1094
2020
Q4
$3.58M Sell
394,330
-138,071
-26% -$1.07M 0.01% 895
2020
Q3
$3.24M Buy
532,401
+35,483
+7% +$271K 0.01% 906
2020
Q2
$4.41M Sell
496,918
-328,595
-40% -$2.83M 0.01% 836
2020
Q1
$5.99M Sell
825,513
-283,566
-26% -$2.1M 0.01% 737
2019
Q4
$9.78M Sell
1,109,079
-71,142
-6% -$532K 0.01% 758
2019
Q3
$7.19M Buy
1,180,221
+704,549
+148% +$3.96M 0.01% 849
2019
Q2
$1.99M Buy
475,672
+224,612
+89% +$1.18M ﹤0.01% 1267
2019
Q1
$1.58M Buy
251,060
+222,656
+784% +$1.56M ﹤0.01% 1409
2018
Q4
$184K Buy
+28,404
New +$217K ﹤0.01% 2092
2018
Q1
Sell
-14,843
Closed -$98K 2290
2017
Q4
$98K Sell
14,843
-382,886
-96% -$2.34M ﹤0.01% 2204
2017
Q3
$2.21M Buy
397,729
+115,836
+41% +$782K ﹤0.01% 1336
2017
Q2
$2.18M Buy
281,893
+225,176
+397% +$1.9M ﹤0.01% 1348
2017
Q1
$511K Sell
56,717
-277,269
-83% -$2.89M ﹤0.01% 1883
2016
Q4
$3.61M Buy
333,986
+72,418
+28% +$966K 0.01% 1167
2016
Q3
$4.27M Sell
261,568
-267,539
-51% -$3.77M 0.01% 1066
2016
Q2
$5.04M Buy
529,107
+147,248
+39% +$1.6M 0.01% 907
2016
Q1
$5.36M Buy
381,859
+29,414
+8% +$304K 0.01% 865
2015
Q4
$3.83M Sell
352,445
-18,052
-5% -$163K 0.01% 992
2015
Q3
$2.52M Buy
370,497
+330,668
+830% +$2.56M 0.01% 1040
2015
Q2
$364K Buy
+39,829
New +$302K ﹤0.01% 1904

Other funds holding NPTN

AQR Capital Management's NPTN Position: Q3 2022 in Review

AQR Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 15,113 shares — an estimated $238K sold.

AQR Capital Management first reported a position in NPTN in Q2 2015 and held it in 26 quarters. The position peaked at $9.78M in Q4 2019. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • AQR Capital Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • AQR Capital Management sold 15,113 NEOPHOTONICS CORP shares in Q3 2022, an estimated $238K.
  • AQR Capital Management first reported a position in NEOPHOTONICS CORP in Q2 2015 and held it in 26 quarters.
  • AQR Capital Management's NEOPHOTONICS CORP position peaked at $9.78M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.